85 related articles for article (PubMed ID: 28445968)
1. USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.
Zhang J; Luo N; Tian Y; Li J; Yang X; Yin H; Xiao C; Sheng J; Li Y; Tang B; Li R
Oncotarget; 2017 Apr; 8(15):24728-24740. PubMed ID: 28445968
[TBL] [Abstract][Full Text] [Related]
2. USP22-JMJD8 axis promotes Lenvatinib resistance in hepatocellular carcinoma.
Guo J; Zhao J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119617. PubMed ID: 37898375
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth.
Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC
PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.
Ye Q; Zhou W; Xu S; Que Q; Zhan Q; Zhang L; Zheng S; Ling S; Xu X
MedComm (2020); 2023 Dec; 4(6):e439. PubMed ID: 38045832
[TBL] [Abstract][Full Text] [Related]
5. Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy.
Xu S; Ling S; Shan Q; Ye Q; Zhan Q; Jiang G; Zhuo J; Pan B; Wen X; Feng T; Lu H; Wei X; Xie H; Zheng S; Xiang J; Shen Y; Xu X
Adv Sci (Weinh); 2021 Mar; 8(5):2003042. PubMed ID: 33717848
[TBL] [Abstract][Full Text] [Related]
6.
Kuang X; McAndrew MJ; Mustachio LM; Chen YC; Atanassov BS; Lin K; Lu Y; Shen J; Salinger A; Macatee T; Dent SYR; Koutelou E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503086
[No Abstract] [Full Text] [Related]
7. Biological effects of ubiquitin-specific peptidase 22 on thyroid papillary cancer cells and its mechanism of action.
Wang HQ; Li Y; Ding SS; Li YX; Wang AC; Shi HY
Transl Cancer Res; 2020 May; 9(5):3703-3711. PubMed ID: 35117732
[TBL] [Abstract][Full Text] [Related]
8. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin Specific Peptidase 22 Regulates Histone H2B Mono-Ubiquitination and Exhibits Both Oncogenic and Tumor Suppressor Roles in Cancer.
Jeusset LM; McManus KJ
Cancers (Basel); 2017 Dec; 9(12):. PubMed ID: 29210986
[TBL] [Abstract][Full Text] [Related]
10. The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.
Wang Y; Sun Q; Mu N; Sun X; Wang Y; Fan S; Su L; Liu X
Cell Commun Signal; 2020 Jul; 18(1):112. PubMed ID: 32665011
[TBL] [Abstract][Full Text] [Related]
11. USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair.
McCann JJ; Vasilevskaya IA; Poudel Neupane N; Shafi AA; McNair C; Dylgjeri E; Mandigo AC; Schiewer MJ; Schrecengost RS; Gallagher P; Stanek TJ; McMahon SB; Berman-Booty LD; Ostrander WF; Knudsen KE
Cancer Res; 2020 Feb; 80(3):430-443. PubMed ID: 31740444
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
[TBL] [Abstract][Full Text] [Related]
13. High expression of ubiquitin carboxyl-terminal hydrolase 22 is associated with poor prognosis in hepatitis B virus-associated liver cancer.
Liao Y; Liang X; Liang W; Li Z; Wang Y; Wang L; Zhen S; Tang B; Wang Z
Oncol Lett; 2019 Jun; 17(6):5159-5168. PubMed ID: 31186731
[TBL] [Abstract][Full Text] [Related]
14. Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.
Kim TH; Yang YM; Han CY; Koo JH; Oh H; Kim SS; You BH; Choi YH; Park TS; Lee CH; Kurose H; Noureddin M; Seki E; Wan YY; Choi CS; Kim SG
J Clin Invest; 2018 Dec; 128(12):5587-5602. PubMed ID: 30300140
[TBL] [Abstract][Full Text] [Related]
15. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
Gennaro VJ; Stanek TJ; Peck AR; Sun Y; Wang F; Qie S; Knudsen KE; Rui H; Butt T; Diehl JA; McMahon SB
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9298-E9307. PubMed ID: 30224477
[TBL] [Abstract][Full Text] [Related]
16. USP22 down-regulation facilitates human retinoblastoma cell aging and apoptosis via inhibiting TERT/P53 pathway.
Zhou D; Liu P; Sun DW; Chen ZJ; Hu J; Peng SM; Liu YL
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2785-2792. PubMed ID: 28682440
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-proteasome pathway-mediated regulation of the Bcl-2 family: effects and therapeutic approaches.
Tang GLQ; Lai JXH; Pervaiz S
Haematologica; 2024 Jan; 109(1):33-43. PubMed ID: 37584295
[TBL] [Abstract][Full Text] [Related]
18. Protein degradation: expanding the toolbox to restrain cancer drug resistance.
Ming H; Li B; Jiang J; Qin S; Nice EC; He W; Lang T; Huang C
J Hematol Oncol; 2023 Jan; 16(1):6. PubMed ID: 36694209
[TBL] [Abstract][Full Text] [Related]
19. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.
Guo J; Zhao J; Fu W; Xu Q; Huang D
Front Immunol; 2022; 13():918314. PubMed ID: 35935969
[TBL] [Abstract][Full Text] [Related]
20. Research Progress of DUB Enzyme in Hepatocellular Carcinoma.
Zhao J; Guo J; Wang Y; Ma Q; Shi Y; Cheng F; Lu Q; Fu W; Ouyang G; Zhang J; Xu Q; Hu X
Front Oncol; 2022; 12():920287. PubMed ID: 35875077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
